Patents Assigned to Merck Patents GmbH
  • Publication number: 20170349761
    Abstract: The present invention relates to compounds of the formula (I) (Rf—CHF—CF2—CHR)m-L-(X)n, where Rf=a perfluorinated alkyl group, optionally containing heteroatoms, R=H or an alkyl group, L=a single bond or a divalent organic group, X=an anchor group, m is ?1 and n is ?1, and to the use thereof in, for example, dirt-repellent coatings.
    Type: Application
    Filed: December 16, 2015
    Publication date: December 7, 2017
    Applicant: Merck Patent GmbH
    Inventor: Reiner FRIEDRICH
  • Publication number: 20170350753
    Abstract: The present invention relates to a spectrophotometer comprising a light source; and a light sensor for measuring the light emitted by the light source and passing through or reflected a sample; and being characterized by an offset generator for applying an offset value to an output of the light sensor. The invention further relates to a method for performing a related spectrophotometric measurement.
    Type: Application
    Filed: November 20, 2015
    Publication date: December 7, 2017
    Applicant: Merck Patent GmbH
    Inventor: Bernhard GUENNEWIG
  • Publication number: 20170348488
    Abstract: An auto injector having sequential control of needle insertion and dose injection is disclosed. A syringe with a needle is movably positioned in a housing between a first position in which the needle is accommodated inside the housing and a second position in which the needle protrudes outside the housing. A plunger rod tube has at least one locking member configured to normally lock a plunger rod to the plunger rod tube. A syringe driver applies a force to the syringe to move the syringe together with plunger rod tube, plunger rod and plunger rod driver from the first position to the second position. In the second position, the locking member is unlocked and releases the plunger rod to thereby activate the plunger rod driver to advance the plunger rod in the syringe for delivering of at least one dose of medicament.
    Type: Application
    Filed: August 18, 2017
    Publication date: December 7, 2017
    Applicant: MERCK PATENT GMBH
    Inventors: Soeren BECHMANN, Flemming MADSEN, Esben W. JOHANSEN
  • Publication number: 20170349760
    Abstract: The present invention relates to novel compounds containing fluorinated end groups and to the use thereof in, for example, dirt-repellent coatings.
    Type: Application
    Filed: December 16, 2015
    Publication date: December 7, 2017
    Applicant: Merck Patent GmbH
    Inventor: Reiner FRIEDRICH
  • Publication number: 20170348380
    Abstract: The present invention relates to pharmaceutical preparations and medicaments for intraarticular administration, comprising pepstatin, and to the preparation and use thereof, in particular in the treatment and/or prophylaxis of arthrosis, traumatic cartilage injuries, arthritis, pain, allodynia or hyperalgesia, particularly preferably in arthrosis.
    Type: Application
    Filed: June 16, 2017
    Publication date: December 7, 2017
    Applicant: Merck Patent GmbH
    Inventors: Markus KLEIN, Ralf WODOPIA, Hans GUEHRING, Sven LINDEMANN
  • Patent number: 9837613
    Abstract: The invention relates to novel polymers containing repeating units based on benzo[2,1,3]thiadiazole-5,6-dicarboxylic acid bis-ester, monomers and methods for their preparation, their use as semiconductors in organic electronic (OE) devices, especially in organic photovoltaic (OPV) devices, and to OE and OPV devices comprising these polymers.
    Type: Grant
    Filed: June 5, 2015
    Date of Patent: December 5, 2017
    Assignee: MERCK PATENT GMBH
    Inventors: William Mitchell, Steven Tierney, Nicolas Blouin, Frank Egon Meyer, Miguel Carrasco-Orozco
  • Patent number: 9837617
    Abstract: The present application relates to a compound of a formula (I) which contains a spirobifluorene basic structure condensed onto a benzofuran unit. The application furthermore relates to a process for the preparation of the compound of the formula (I), and to the use of the compound of the formula (I) in an electronic device.
    Type: Grant
    Filed: June 30, 2017
    Date of Patent: December 5, 2017
    Assignee: Merck Patent GmbH
    Inventors: Jochen Pfister, Frank Voges, Elvira Montenegro, Teresa Mujica-Fernaud
  • Patent number: 9834541
    Abstract: The invention provides novel substituted 2-aminopyridine compounds according to Formula (I), their manufacture and use for the treatment of hyperproliferative diseases such as cancer, inflammatory or degenerative diseases.
    Type: Grant
    Filed: October 2, 2013
    Date of Patent: December 5, 2017
    Assignees: CANCER RESEARCH TECHNOLOGY LIMITED, MERCK PATENT GMBH
    Inventors: Kai Schiemann, Frank Stieber, Julian Blagg, Aurelie Mallinger, Dennis Waalboer, Christian Rink, Simon Ross Crumpler
  • Patent number: 9837622
    Abstract: The present invention relates to metal complexes and to electronic devices, in particular organic electroluminescent devices, comprising these metal complexes.
    Type: Grant
    Filed: June 21, 2013
    Date of Patent: December 5, 2017
    Assignee: MERCK PATENT GMBH
    Inventors: Philipp Stoessel, Dominik Joosten, Esther Breuning, Joachim Kaiser, Christian Ehrenreich
  • Patent number: 9835943
    Abstract: The present invention relates to a process for the laser treatment of effect pigment-containing coatings, to coatings produced using this process, and to the use thereof in decorative and security products.
    Type: Grant
    Filed: May 21, 2015
    Date of Patent: December 5, 2017
    Assignee: MERCK PATENT GMBH
    Inventors: Matthias Quenzer, Sylke Klein
  • Publication number: 20170342372
    Abstract: The present invention relates to dry cell culture media comprising amino acid components of certain particle size. Some dry powder cell culture media show poor dissolving properties and result in turbid solutions when they are dissolved in aqueous solutions. Using amino acid components of certain particle sizes significantly reduces that problem.
    Type: Application
    Filed: November 13, 2015
    Publication date: November 30, 2017
    Applicant: Merck Patent GmbH
    Inventor: Joerg VON HAGEN
  • Publication number: 20170343712
    Abstract: The present invention relates to a polarized light emissive device and a method for its manufacture comprising a plural of fluorescent semiconductor quantum rods, and to a preparation thereof. The invention further relates to a use of the polarized light emissive device in optical devices, and to an optical device comprising the polarized light emissive device.
    Type: Application
    Filed: November 18, 2015
    Publication date: November 30, 2017
    Applicant: MERCK PATENT GMBH
    Inventors: Masaki HASEGAWA, Noriyuki MATSUDA
  • Publication number: 20170340635
    Abstract: A pharmaceutical composition of 3-(1-{3-[5-(1-Methyl-piperidin-4-ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo-1,6-dihydro-pyridazin-3-yl)-benzonitrile or a pharmaceutically acceptable salt and/or solvate thereof in combination with 4-[(S)-2-azetidin-1-yl-1-(4-chloro-3-trifluoromethyl-phenyl)-ethylamino]-quinazoline-8-carboxylic acid amide.
    Type: Application
    Filed: November 12, 2015
    Publication date: November 30, 2017
    Applicant: MERCK PATENT GMBH
    Inventors: Friedhelm BLADT, Manja FRIESE-HAMIM
  • Publication number: 20170342324
    Abstract: The invention relates to bimesogenic compounds of formula I wherein R11, R12, MG11, MG12 and CG1 have the meaning given in claim 1, to the use of bimesogenic compounds of formula I in liquid crystal media and particular to flexoelectric liquid crystal devices comprising a liquid crystal medium according to the present invention.
    Type: Application
    Filed: November 23, 2015
    Publication date: November 30, 2017
    Applicant: Merck Patent GmbH
    Inventors: Kevin ADLEM, Patricia Eileen SAXTON
  • Publication number: 20170343847
    Abstract: The invention relates to a light modulation element comprising a cholesteric liquid crystalline medium sandwiched between two substrates, each provided with an electrode structure, wherein at least one of the substrates is additionally provided with an alignment layer which is provided with a photoresist pattern consisting of periodic substantially parallel stripes. The invention is further related to a method of production of said light modulation element and to the use of said light modulation element in various types of optical and electro-optical devices, such as electro-optical displays, liquid crystal displays (LCDs), non-linear optic (NLO) devices, and optical information storage devices.
    Type: Application
    Filed: October 8, 2015
    Publication date: November 30, 2017
    Applicant: Merck Patent GmbH
    Inventors: Bernd FIEBRANZ, Meike KRUMWIEDE, Simon SIEMIANOWSKI
  • Publication number: 20170340989
    Abstract: The present invention refers to a method for the separation of peptide aggregates and fragments from solutions containing target peptide.
    Type: Application
    Filed: November 18, 2015
    Publication date: November 30, 2017
    Applicant: MERCK PATENT GMBH
    Inventors: Romas SKUDAS, Klaus ADRIAN, Bianca EDELMANN, Matthias JOEHNCK
  • Patent number: 9831446
    Abstract: The present invention relates to metal complexes and to electronic devices, in particular organic electroluminescent devices, comprising these metal complexes.
    Type: Grant
    Filed: September 11, 2013
    Date of Patent: November 28, 2017
    Assignee: MERCK PATENT GMBH
    Inventors: Philipp Stoessel, Joachim Kaiser, Dominik Joosten, Nils Koenen, Esther Breuning
  • Patent number: 9831441
    Abstract: The invention relates to an electronic device containing at least one compound of formula (I) or (II) in an organic layer. The invention further relates to a method for producing the electronic device and the use of a compound of formula (I) or (II) in an electronic device.
    Type: Grant
    Filed: October 11, 2013
    Date of Patent: November 28, 2017
    Assignee: Merck Patent GmbH
    Inventors: Amir Hossain Parham, Irina Martynova, Elvira Montenegro, Teresa Mujica-Fernaud, Frank Voges, Arne Buesing
  • Patent number: 9831448
    Abstract: The invention relates to metal complexes and to electronic devices, in particular organic electroluminescence devices, containing said metal complexes.
    Type: Grant
    Filed: August 12, 2014
    Date of Patent: November 28, 2017
    Assignee: Merck Patent GmbH
    Inventors: Philipp Stoessel, Nils Koenen, Esther Breuning
  • Publication number: 20170335192
    Abstract: A polymerisable LC material comprising at least one di- or multireactive mesogenic compound selected from the group of compounds of formula I, at least one monoreactive mesogenic compound selected from the group of compounds of formula II, wherein the parameter A11 to A21, L21, p, P11 to P22, R21, Sp11 to Sp21, X11 to X21, and Z11 to Z21 have one of the meanings as given in claim 1, and at least one carbazole oxime ester photoinitiator. Furthermore, a method for preparation of the polymerisable LC material, a polymer film with improved thermal durability obtainable from the corresponding polymerisable LC material, a method of preparation of such polymer film, and the use of such polymer film and said polymerisable LC material for optical, electro-optical, decorative or security devices.
    Type: Application
    Filed: May 16, 2017
    Publication date: November 23, 2017
    Applicant: Merck Patent GmbH
    Inventors: Stephen MULCAHY, Iain GARDINER, Jack BRADFORD, Eduardo BELTRAN GRACIA, Graham SMITH